455 related articles for article (PubMed ID: 26935961)
41. Catheter-related infections in patients with acute type II intestinal failure admitted to a national centre: Incidence and outcomes.
Bond A; Teubner A; Taylor M; Cawley C; Varden J; Abraham A; Chadwick PR; Soop M; Carlson GL; Lal S
Clin Nutr; 2019 Aug; 38(4):1828-1832. PubMed ID: 30086999
[TBL] [Abstract][Full Text] [Related]
42. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
[TBL] [Abstract][Full Text] [Related]
43. Use of selective gut decontamination in critically ill children: PICnIC a pilot RCT and mixed-methods study.
Brown A; Ferrando-Vivas P; Popa M; de la Fuente GM; Pappachan J; Cuthbertson BH; Drikite L; Feltbower R; Gouliouris T; Sale I; Shulman R; Tume LN; Myburgh J; Woolfall K; Harrison DA; Mouncey PR; Rowan K; Pathan N
Health Technol Assess; 2024 Feb; 28(8):1-84. PubMed ID: 38421007
[TBL] [Abstract][Full Text] [Related]
44. Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial).
Pickard R; Starr K; MacLennan G; Kilonzo M; Lam T; Thomas R; Burr J; Norrie J; McPherson G; McDonald A; Shearer K; Gillies K; Anson K; Boachie C; N'Dow J; Burgess N; Clark T; Cameron S; McClinton S
Health Technol Assess; 2015 Aug; 19(63):vii-viii, 1-171. PubMed ID: 26244520
[TBL] [Abstract][Full Text] [Related]
45. Patient and central venous catheter related risk factors for blood stream infections in children receiving chemotherapy.
Yacobovich J; Ben-Ami T; Abdalla T; Tamary H; Goldstein G; Weintraub M; Yaniv I; Toren A; Kenet G; Revel-Vilk S
Pediatr Blood Cancer; 2015 Mar; 62(3):471-6. PubMed ID: 25327811
[TBL] [Abstract][Full Text] [Related]
46. Prevention of catheter-related blood stream infection: back to basics?
Cherry-Bukowiec JR; Denchev K; Dickinson S; Chenoweth CE; Zalewski C; Meldrum C; Sihler KC; Brunsvold ME; Papadimos TJ; Park PK; Napolitano LM
Surg Infect (Larchmt); 2011 Feb; 12(1):27-32. PubMed ID: 21171811
[TBL] [Abstract][Full Text] [Related]
47. [Prevention of catheter-related infection: usefulness and cost-effectiveness of antiseptic catheters in children].
Lenz AM; Vassallo JC; Moreno GE; Althabe M; Gómez S; Magliola R; Casimir L; Bologna R; Barretta J; Ruffa P
Arch Argent Pediatr; 2010 Jun; 108(3):209-15. PubMed ID: 20544135
[TBL] [Abstract][Full Text] [Related]
48. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2015 Nov; (11):CD010996. PubMed ID: 26590504
[TBL] [Abstract][Full Text] [Related]
49. Impact of infection control training for interns on PICU-acquired bloodstream infections in a middle-income country.
Ng YY; Abdel-Latif Mel-A; Gan CS; Siham A; Zainol H; Lum LC
Singapore Med J; 2015 Sep; 56(9):506-12. PubMed ID: 26451053
[TBL] [Abstract][Full Text] [Related]
50. Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation) study.
Wolf A; McKay A; Spowart C; Granville H; Boland A; Petrou S; Sutherland A; Gamble C
Health Technol Assess; 2014 Dec; 18(71):1-212. PubMed ID: 26099138
[TBL] [Abstract][Full Text] [Related]
51. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
52. Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.
Brunelli SM; Van Wyck DB; Njord L; Ziebol RJ; Lynch LE; Killion DP
J Am Soc Nephrol; 2018 Apr; 29(4):1336-1343. PubMed ID: 29472415
[TBL] [Abstract][Full Text] [Related]
53. Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants.
McMullan RL; Gordon A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012181. PubMed ID: 29512818
[TBL] [Abstract][Full Text] [Related]
54. Types of urethral catheters for management of short-term voiding problems in hospitalised adults.
Brosnahan J; Jull A; Tracy C
Cochrane Database Syst Rev; 2004; (1):CD004013. PubMed ID: 14974052
[TBL] [Abstract][Full Text] [Related]
55. A multicentre, randomised controlled trial comparing the clinical effectiveness and cost-effectiveness of early nutritional support via the parenteral versus the enteral route in critically ill patients (CALORIES).
Harvey SE; Parrott F; Harrison DA; Sadique MZ; Grieve RD; Canter RR; McLennan BK; Tan JC; Bear DE; Segaran E; Beale R; Bellingan G; Leonard R; Mythen MG; Rowan KM
Health Technol Assess; 2016 Apr; 20(28):1-144. PubMed ID: 27089843
[TBL] [Abstract][Full Text] [Related]
56. A multicentre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and health-care resource use following cardiac surgery (TITRe2).
Reeves BC; Pike K; Rogers CA; Brierley RC; Stokes EA; Wordsworth S; Nash RL; Miles A; Mumford AD; Cohen A; Angelini GD; Murphy GJ
Health Technol Assess; 2016 Aug; 20(60):1-260. PubMed ID: 27527344
[TBL] [Abstract][Full Text] [Related]
57. Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial.
Bueloni TNV; Marchi D; Caetano C; de Souza Cavalcante R; Mendes Amaral ML; Ponce D
Int J Infect Dis; 2019 Aug; 85():16-21. PubMed ID: 31102823
[TBL] [Abstract][Full Text] [Related]
58. The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections.
Chaftari AM; El Zakhem A; Jamal MA; Jiang Y; Hachem R; Raad I
BMC Infect Dis; 2014 Sep; 14():518. PubMed ID: 25253042
[TBL] [Abstract][Full Text] [Related]
59. A randomised controlled trial to measure the effects and costs of a dental caries prevention regime for young children attending primary care dental services: the Northern Ireland Caries Prevention In Practice (NIC-PIP) trial.
Tickle M; O'Neill C; Donaldson M; Birch S; Noble S; Killough S; Murphy L; Greer M; Brodison J; Verghis R; Worthington HV
Health Technol Assess; 2016 Sep; 20(71):1-96. PubMed ID: 27685609
[TBL] [Abstract][Full Text] [Related]
60. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.
Veenstra DL; Saint S; Sullivan SD
JAMA; 1999 Aug; 282(6):554-60. PubMed ID: 10450717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
